MaxCyte Inc (MXCT)
3.55
+0.10
(+2.90%)
USD |
NASDAQ |
Nov 22, 16:00
3.565
+0.02
(+0.42%)
After-Hours: 20:00
MaxCyte Profit Margin (Quarterly): -141.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -141.6% |
| June 30, 2024 | -89.89% |
| March 31, 2024 | -83.99% |
| December 31, 2023 | -33.69% |
| September 30, 2023 | -140.6% |
| June 30, 2023 | -116.2% |
| March 31, 2023 | -126.9% |
| December 31, 2022 | -38.72% |
| September 30, 2022 | -60.45% |
| Date | Value |
|---|---|
| June 30, 2022 | -85.97% |
| March 31, 2022 | -35.10% |
| December 31, 2021 | -48.01% |
| September 30, 2021 | -26.44% |
| June 30, 2021 | -62.21% |
| March 31, 2021 | -109.4% |
| December 31, 2020 | -31.15% |
| September 30, 2020 | -45.82% |
| June 30, 2020 | -58.33% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-141.6%
Minimum
Sep 2024
-26.44%
Maximum
Sep 2021
-74.14%
Average
-61.33%
Median
Profit Margin (Quarterly) Benchmarks
| Cutera Inc | -120.1% |
| IRIDEX Corp | -16.69% |
| Stereotaxis Inc | -67.31% |
| Electromed Inc | 10.05% |
| Myomo Inc | -10.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.86% |
| Return on Assets | -13.82% |
| Return on Invested Capital | -15.86% |
| Gross Profit Margin (Quarterly) | 76.38% |
| Operating Margin (Quarterly) | -172.1% |
| Return on Net Operating Assets | -70.36% |